Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  fatigue
Country:  U.S.A.
Trial Type:  Supportive care
Results 1-25 of 43 for your search:
Start Over
Yoga or Stretching and Relaxation in Improving Physical Function in Patients with Stage 0-III Breast Cancer Undergoing Radiation Therapy
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: 2009-0976, NCI-2012-01895, NCT01202851
Armodafinil in Reducing Cancer-Related Fatigue in Patients with High-Grade Glioma
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: A221101, NCI-2012-02020, N10C3, NCT01781468
Therapeutic Melatonin in Treating Cancer-Related Fatigue in Breast Cancer Patients Undergoing Radiation Therapy
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: MCC-12-08248, NCI-2015-00345, NCI-2015-00317, NCT02332928
The Effects of Ginseng on Cancer-Related Fatigue
Phase: Phase II, Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: 2009-0854, NCI-2011-01127, NCT01375114
Acupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Related Joint Pain
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: UPCC 07109, NCI-2009-01358, NCT01013337
Modafinil in Treating Children with Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
Phase: Phase II
Type: Supportive care
Age: 6 to 19
Trial IDs: ACCL0922, NCI-2011-02594, CDR0000702733, SCUSF 0901, NCT01381718
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Patients with Previously Untreated Mantle Cell Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 60 and over
Trial IDs: E1411, NCI-2011-02980, CDR0000707057, ECOG-E1411, NCT01415752
Cognitive Behavioral Therapy, Exercise, and Methylphenidate Hydrochloride in Reducing Fatigue in Patients with Prostate Cancer Receiving Radiation Therapy
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 2011-0389, NCI-2011-02764, RSG-11-170-01-PCSM, NCT01410942
Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients with Cancer
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 2012-0120, NCI-2012-01352, NCT01628029
Yoga in Decreasing Inflammation, Fatigue, and Depressive Symptoms in Breast Cancer Survivors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 21 and over
Trial IDs: OSU-06137, NCI-2012-00564, 2007C0004, OSU-2007C0004, NCT00486525
Minocycline Hydrochloride in Reducing the Side Effects of Surgery in Patients with Head and Neck Cancer
Phase: Phase II
Type: Supportive care
Age: Over 18
Trial IDs: 2013-0510, NCI-2014-01979, NCT02055963
Ruxolitinib Phosphate in Reducing Fatigue in Patients with Chronic Lymphocytic Leukemia
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 2013-0044, NCI-2014-01465, NCT02131584
Naltrexone Hydrochloride in Reducing Radiation Therapy Related Fatigue in Patients with Breast Cancer
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 14-056, NCI-2014-02031, NCT02137252
Exercise Intervention in Increasing Physical Activity in Patients with Early Stage Breast Cancer Receiving Chemotherapy
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: D12030, NCI-2014-01537, CPHS 27955, STUDY00027955, NCT02159157
Short-Term Dexamethasone in Treating Fatigue in Patients with Head and Neck Cancer or Non-small Cell Lung Cancer Undergoing Radiation Therapy
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 1408439554, NCI-2015-01119, 1408439554A010, NCT02410382
Problem-Solving Occupational Therapy in Reducing Disability in Older Cancer Survivors
Phase: Phase I
Type: Supportive care
Age: 65 and over
Trial IDs: D12110, NCI-2013-01704, 23556, NCT01709344
Supervised Aerobic Training or Progressive Stretching in Improving Quality of Life in Patients with Metastatic Breast Cancer Receiving Anticancer Therapy
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Age: 21 to 80
Trial IDs: 14-170, NCI-2014-00079, NCT02239848, NCT01725633
Melatonin in Treating Childhood Cancer Survivors with Neurocognitive Problems or Sleep Disorders
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: MIND, NCI-2012-02053, NCT01700959
Meditation in Reducing Stress During Chemotherapy in Patients With Stage I-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: OS12706, NCI-2013-01401, 2013-0027, NCT01790789
Neurocognitive Function in Patients With Newly Diagnosed Brain Metastases Undergoing Stereotactic Radiosurgery
Phase: No phase specified
Type: Health services research, Supportive care, Treatment
Age: 18 and over
Trial IDs: 12105, NCI-2013-01358, NAGKC 12-02, NCT01821443
Iobenguane I 131 in Treating Patients With Refractory Neuroblastoma or Metastatic Pheochromocytoma
Phase: No phase specified
Type: Supportive care, Treatment
Age: 1 and over
Trial IDs: 2012LS107, NCI-2013-01933, NCT01850888
Acetylcysteine in Treating Patients with Stage 0-I Breast Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 12D.396, NCI-2014-01868, 2012-45, NCT01878695
Physical Activity in Reducing Joint Pain in Breast Cancer Survivors Receiving Hormone Therapy
Phase: No phase specified
Type: Supportive care
Age: 21 and over
Trial IDs: LCCC1312, NCI-2014-02557, 13-2321, NCT01900418
Media Diversion in Improving Quality of Life in Patients with Recurrent Gynecologic Cancers Receiving Chemotherapy
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: UW13037, NCI-2013-01284, 2013-0618, 2013-0618-CP004, 2013-0618-CR002, NCT01901835
Massage Therapy Compared to Light Touch Therapy in Decreasing Cancer-Related Fatigue in Breast Cancer Survivors
Phase: No phase specified
Type: Supportive care
Age: 18 to 65
Trial IDs: R21AT007090, NCI-2014-01419, IRB00062853, mCRF, NCT01926678
Start Over